Clinical importance of the comprehensive etiopathogenetic classification of mushroom poisoning
Roč. 57, č. 1 (2003), s. 35-41.
Ľubomír Michalko, Tomáš KollerExpandable stents in the treatment of benign and malignant tumors of the esophagus
Review articleGastroent Hepatol 2014; 68(5): 441–450. doi:10.14735/amgh2014441
SummaryLiteraturepdf Tibor Hlavatý, Martin Huorka, Tomáš Koller, Jozef TóthPrognostic factors and timing of endoscopy in acute non-variceal upper gastrointestinal bleeding
Original articleGastroent Hepatol 2011; 65(5): 286-293.
Summarypdf Jaroslav Sekáč, Martin Huorka, Magdaléna Nagyová, Tibor Hlavatý, Juraj Payer, Tomáš KollerDiagnosis and management of patients suffering from non-alcoholic fatty liver disease
Current overviewČes a Slov Gastroent a Hepatol 2007; 61(2): 96-102.
Summary Tomáš KollerEndocrine manifestation of liver diseases
Current overviewČes a Slov Gastroent a Hepatol 2007; 61(3): 150-154.
Summary Juraj Payer, Tomáš KollerBiosimilar infliximab CT-P13 treatment in patients with inflammatory bowel diseases – a one-year, single-centre retrospective study
Original articleGastroent Hepatol 2016; 70(1): 27–36. doi:10.14735/amgh201627
SummaryLiteraturepdf Tibor Hlavatý, Anna Krajčovičová, Igor Šturdík, Juraj Letkovský, Tomáš Koller, Jozef Tóth, Martin HuorkaGuidelines of the IBD working group of the Slovak Gastroenterology Society on the management of ulcerative colitis
GuidelinesGastroent Hepatol 2017; 71(3): 229–240. doi:10.14735/amgh2017csgh.info05
Literaturepdf Tibor Hlavatý, Anna Krajčovičová, Mária Zakuciová, Miloš Greguš, Igor Šturdík, Tomáš Koller, Jozef Baláž, Martin Huorka, Pracovná skupina pre IBD SGSGuidelines of the IBD working group of the Slovak Society of Gastroenterology on the management of Crohn’s disease
GuidelinesGastroent Hepatol 2018; 72(1): 27–40. doi:10.14735/amgh201827
Literaturepdf Tomáš Koller, Jozef Tóth, Tibor Hlavatý, Mária Zakuciová, Anna Krajčovičová, Miloš Greguš, Jozef Baláž, Igor Šturdík, Martin Huorka, Pracovná skupina pre IBD SGSGuidelines of the IBD working group of the SGS on the management on the IBD – optimizing biological treatment in the IBD after loos of response
GuidelinesGastroent Hepatol 2018; 72(5): 426–431. doi:10.14735/amgh2018426
Literaturepdf Miloš Greguš, Tibor Hlavatý, Anna Krajčovičová, Laura Gombošová, Tomáš Koller, Martin Huorka, Mária Zakuciová, Igor Šturdík, Pracovná skupina pre IBD SGS